OCULUS/RUTHIGEN SC13G

Company

Sonoma Pharmaceuticals, Inc.

Filed

April 10, 2014

Accession Number

0001019687-14-001340

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →